company background image
VETO logo

Vetoquinol ENXTPA:VETO Stock Report

Last Price

€95.20

Market Cap

€1.1b

7D

-1.9%

1Y

7.8%

Updated

21 Jun, 2024

Data

Company Financials +

VETO Stock Overview

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

VETO fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Vetoquinol SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vetoquinol
Historical stock prices
Current Share Price€95.20
52 Week High€110.00
52 Week Low€76.30
Beta0.92
11 Month Change-8.99%
3 Month Change-5.37%
1 Year Change7.81%
33 Year Change-12.01%
5 Year Change64.14%
Change since IPO313.91%

Recent News & Updates

Recent updates

An Intrinsic Calculation For Vetoquinol SA (EPA:VETO) Suggests It's 40% Undervalued

Jun 15
An Intrinsic Calculation For Vetoquinol SA (EPA:VETO) Suggests It's 40% Undervalued

Why We're Not Concerned About Vetoquinol SA's (EPA:VETO) Share Price

May 01
Why We're Not Concerned About Vetoquinol SA's (EPA:VETO) Share Price

Here's What Analysts Are Forecasting For Vetoquinol SA (EPA:VETO) After Its Annual Results

Mar 24
Here's What Analysts Are Forecasting For Vetoquinol SA (EPA:VETO) After Its Annual Results

With EPS Growth And More, Vetoquinol (EPA:VETO) Makes An Interesting Case

Jan 13
With EPS Growth And More, Vetoquinol (EPA:VETO) Makes An Interesting Case

Vetoquinol SA (EPA:VETO) Shares Could Be 32% Below Their Intrinsic Value Estimate

Dec 19
Vetoquinol SA (EPA:VETO) Shares Could Be 32% Below Their Intrinsic Value Estimate

Vetoquinol (EPA:VETO) Seems To Use Debt Quite Sensibly

Nov 23
Vetoquinol (EPA:VETO) Seems To Use Debt Quite Sensibly

Here's Why We Think Vetoquinol (EPA:VETO) Is Well Worth Watching

Oct 06
Here's Why We Think Vetoquinol (EPA:VETO) Is Well Worth Watching

Is Vetoquinol SA (EPA:VETO) Trading At A 45% Discount?

Sep 12
Is Vetoquinol SA (EPA:VETO) Trading At A 45% Discount?

Are Investors Undervaluing Vetoquinol SA (EPA:VETO) By 28%?

May 24
Are Investors Undervaluing Vetoquinol SA (EPA:VETO) By 28%?

Is Vetoquinol (EPA:VETO) Using Too Much Debt?

May 03
Is Vetoquinol (EPA:VETO) Using Too Much Debt?

Vetoquinol SA (EPA:VETO) Shares Could Be 22% Below Their Intrinsic Value Estimate

Jan 05
Vetoquinol SA (EPA:VETO) Shares Could Be 22% Below Their Intrinsic Value Estimate

Here's Why Vetoquinol (EPA:VETO) Has Caught The Eye Of Investors

Dec 01
Here's Why Vetoquinol (EPA:VETO) Has Caught The Eye Of Investors

We Think Vetoquinol (EPA:VETO) Can Stay On Top Of Its Debt

Oct 07
We Think Vetoquinol (EPA:VETO) Can Stay On Top Of Its Debt

Vetoquinol SA (EPA:VETO) Shares Could Be 31% Below Their Intrinsic Value Estimate

Aug 19
Vetoquinol SA (EPA:VETO) Shares Could Be 31% Below Their Intrinsic Value Estimate

Do Vetoquinol's (EPA:VETO) Earnings Warrant Your Attention?

Jul 16
Do Vetoquinol's (EPA:VETO) Earnings Warrant Your Attention?

Vetoquinol SA (EPA:VETO) Shares Could Be 29% Below Their Intrinsic Value Estimate

May 07
Vetoquinol SA (EPA:VETO) Shares Could Be 29% Below Their Intrinsic Value Estimate

I Ran A Stock Scan For Earnings Growth And Vetoquinol (EPA:VETO) Passed With Ease

Apr 06
I Ran A Stock Scan For Earnings Growth And Vetoquinol (EPA:VETO) Passed With Ease

Calculating The Intrinsic Value Of Vetoquinol SA (EPA:VETO)

Dec 21
Calculating The Intrinsic Value Of Vetoquinol SA (EPA:VETO)

Is Vetoquinol (EPA:VETO) Using Too Much Debt?

Nov 29
Is Vetoquinol (EPA:VETO) Using Too Much Debt?

Estimating The Intrinsic Value Of Vetoquinol SA (EPA:VETO)

Sep 10
Estimating The Intrinsic Value Of Vetoquinol SA (EPA:VETO)

Is Vetoquinol (EPA:VETO) A Risky Investment?

Aug 01
Is Vetoquinol (EPA:VETO) A Risky Investment?

Is Vetoquinol SA (EPA:VETO) Trading At A 35% Discount?

May 12
Is Vetoquinol SA (EPA:VETO) Trading At A 35% Discount?

Vetoquinol SA's (EPA:VETO) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Feb 11
Vetoquinol SA's (EPA:VETO) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

A Look At The Intrinsic Value Of Vetoquinol SA (EPA:VETO)

Jan 20
A Look At The Intrinsic Value Of Vetoquinol SA (EPA:VETO)

Vetoquinol (EPA:VETO) Shareholders Have Enjoyed An Impressive 111% Share Price Gain

Dec 29
Vetoquinol (EPA:VETO) Shareholders Have Enjoyed An Impressive 111% Share Price Gain

How Much Is Vetoquinol SA (EPA:VETO) Paying Its CEO?

Dec 09
How Much Is Vetoquinol SA (EPA:VETO) Paying Its CEO?

We Think Vetoquinol's (EPA:VETO) Statutory Profit Might Understate Its Earnings Potential

Nov 18
We Think Vetoquinol's (EPA:VETO) Statutory Profit Might Understate Its Earnings Potential

Shareholder Returns

VETOFR PharmaceuticalsFR Market
7D-1.9%0.8%1.3%
1Y7.8%-9.8%2.3%

Return vs Industry: VETO exceeded the French Pharmaceuticals industry which returned -8.2% over the past year.

Return vs Market: VETO exceeded the French Market which returned 2.2% over the past year.

Price Volatility

Is VETO's price volatile compared to industry and market?
VETO volatility
VETO Average Weekly Movement3.5%
Pharmaceuticals Industry Average Movement3.5%
Market Average Movement4.8%
10% most volatile stocks in FR Market9.4%
10% least volatile stocks in FR Market2.6%

Stable Share Price: VETO has not had significant price volatility in the past 3 months.

Volatility Over Time: VETO's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19332,440Matthieu Frechinwww.vetoquinol.com

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France.

Vetoquinol SA Fundamentals Summary

How do Vetoquinol's earnings and revenue compare to its market cap?
VETO fundamental statistics
Market cap€1.13b
Earnings (TTM)€55.56m
Revenue (TTM)€529.27m

20.3x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VETO income statement (TTM)
Revenue€529.27m
Cost of Revenue€237.89m
Gross Profit€291.38m
Other Expenses€235.82m
Earnings€55.56m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Sep 12, 2024

Earnings per share (EPS)4.70
Gross Margin55.05%
Net Profit Margin10.50%
Debt/Equity Ratio0.6%

How did VETO perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

18%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.